Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | 6.04% | -31.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.89% | -39.28% | |||
| Operating Income | -14.12% | 39.67% | |||
| Income Before Tax | -16.76% | 40.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.76% | 40.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.76% | 40.40% | |||
| EBIT | -14.12% | 39.67% | |||
| EBITDA | -14.22% | 39.73% | |||
| EPS Basic | 16.61% | 40.32% | |||
| Normalized Basic EPS | 16.78% | 40.14% | |||
| EPS Diluted | 16.61% | 40.32% | |||
| Normalized Diluted EPS | 16.78% | 40.14% | |||
| Average Basic Shares Outstanding | 40.03% | -0.13% | |||
| Average Diluted Shares Outstanding | 40.03% | -0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||